Ei-ichiro Suzuki

Publication List Details

Period

1995 - 2009

Number

21

Co-Authors

A Simple Stabilization Method of Reduced Albumin in Blood and Plasma for the Reduced/Oxidized Albumin Ratio Measurement (2009)

Kazuyuki Kubota, Naoyuki Yamada, Ei-ichiro Suzuki, Akira Nakayama, Kenji Takehana, Asami Kawakami

Albumin (Alb) is mixture of reduced and oxidized forms. It is physiologically significant to determine Alb(red)%, which is the proportion of reduced Alb in the sum of Alb. However, reduced Alb in...

Substrate specificity of microbial transglutaminase as revealed by three-dimensional docking simulation and mutagenesis (2009)

Tagami, Uno, Shimba, Nobuhisa, Nakamura, Mina, Yokoyama, Kei-ichi, Suzuki, Ei-ichiro, Hirokawa, Takatsugu

Transglutaminases (TGases) are used in fields such as food and pharmaceuticals. Unlike other TGases, microbial transglutaminase (MTG) activity is Ca2+-independent, broadening its application. Here, a...

Enlarged FAMSBASE: protein 3D structure models of genome sequences for 41 species (2008)

Akihiro Yamaguchi, Mitsuo Iwadate, Ei-ichiro Suzuki, Kei Yura, Shigetsugu Kawakita, Hideaki Umeyama, ...

Enlarged FAMSBASE is a relational database of comparative protein structure models for the whole genome of 41 species,presented in the GTOP database. The models are calculated by Full

Prognostic Factors in Patients with Gemcitabine-Refractory Pancreatic Cancer (2007)

Nakachi, Kohei, Furuse, Junji, Ishii, Hiroshi, Suzuki, Ei-ichiro, Yoshino, Masahiro

Objective The purpose of this study was to identify prognostic factors in patients with gemcitabine-refractory pancreatic cancer and to determine criteria for selecting candidates for second-line...

Prognostic Factors in Patients with Gemcitabine-Refractory Pancreatic Cancer (2007)

Nakachi, Kohei, Furuse, Junji, Ishii, Hiroshi, Suzuki, Ei-ichiro, Yoshino, Masahiro

Objective The purpose of this study was to identify prognostic factors in patients with gemcitabine-refractory pancreatic cancer and to determine criteria for selecting candidates for second-line...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

The Energetic Conversion Competence of Escherichia coli during Aerobic Respiration Studied by 31P NMR Using a Circulating Fermentation System (2004)

Noguchi, Yasushi, Nakai, Yuta, Shimba, Nobuhisa, Toyosaki, Hiroshi, Kawahara, Yoshio, Sugimoto, Shinichi, ...

To determine the actual potential of the energetic conversion efficiency of Escherichia coli during aerobic respiration, apparent P/O ratios (P/Oapp) under either limited or standard glucose-feeding...

Enlarged FAMSBASE: protein 3D structure models of genome sequences for 41 species (2003)

Yamaguchi, Akihiro, Iwadate, Mitsuo, Suzuki, Ei-ichiro, Yura, Kei, Kawakita, Shigetsugu, Umeyama, Hideaki, ...

Enlarged FAMSBASE is a relational database of comparative protein structure models for the whole genome of 41 species, presented in the GTOP database. The models are calculated by Full Automatic...

Enhancement of nucleoside phosphorylation activity in an acid phosphatase (2002)

Ishikawa, Kohki, Mihara, Yasuhiro, Shimba, Nobuhisa, Ohtsu, Naoko, Kawasaki, Hisashi, Suzuki, Ei-ichiro, ...

Escherichia blattae non-specific acid phosphatase (EB-NSAP) possesses a pyrophosphate-nucleoside phosphotransferase activity, which is C-5′-position selective. Current mutational and structural...

Structural analysis of the complex of a distamycin analogue with the Dickerson dodecamer 13C labeled at 5'-carbons using NMR spectroscopy (1999)

Kawashima, Etsuko, Shimba, Nobuhisa, Suzuki, Ei-ichiro, Ishido, Yoshiharu

Structural analysis of the complex of a distamycin analogue (Tallimustine) with the Dickerson dodecamer d(C*G*C*G*A*A*T*T*C*G*C*G) {N*:[5′-13C]nucleotide} was performed by NMR spectroscopy and the...

Effects of Replacement of Lys25 with Gln on the Conformation of Ribonuclease T1: Sequence-Specific 1H NMR Resonance Assignments of Gln25 Ribonuclease T1 by Two-Dimensional NMR Spectroscopy (1995)

Kojima, Masaki, Miyano, Hiroshi, Suzuki, Ei-ichiro, Tanokura, Masaru, Takahashi, Kenji

Two isozymes of ribonuclease (RNase) T1 exist in nature, i.e., Gln25 RNase T1 and Lys25 RNase T1. Gln25 RNase T1 is less stable than Lys25 RNase T1, although the enzymatic activity is not...

Enlarged FAMSBASE: protein 3D structure models of genome sequences for 41 species

Yamaguchi, Akihiro, Iwadate, Mitsuo, Suzuki, Ei-ichiro, Yura, Kei, Kawakita, Shigetsugu, Umeyama, Hideaki, ...

Enlarged FAMSBASE is a relational database of comparative protein structure models for the whole genome of 41 species, presented in the GTOP database. The models are calculated by Full Automatic...

X-ray structures of a novel acid phosphatase from Escherichia blattae and its complex with the transition-state analog molybdate

Ishikawa, Kohki, Mihara, Yasuhiro, Gondoh, Keiko, Suzuki, Ei-ichiro, Asano, Yasuhisa

The structure of Escherichia blattae non-specific acid phosphatase (EB-NSAP) has been determined at 1.9 Å resolution with a bound sulfate marking the phosphate-binding site. The enzyme is a 150 kDa...

Enlarged FAMSBASE: protein 3D structure models of genome sequences for 41 species

Yamaguchi, Akihiro, Iwadate, Mitsuo, Suzuki, Ei-ichiro, Yura, Kei, Kawakita, Shigetsugu, Umeyama, Hideaki, ...

Enlarged FAMSBASE is a relational database of comparative protein structure models for the whole genome of 41 species, presented in the GTOP database. The models are calculated by Full Automatic...

X-ray structures of a novel acid phosphatase from Escherichia blattae and its complex with the transition-state analog molybdate

Ishikawa, Kohki, Mihara, Yasuhiro, Gondoh, Keiko, Suzuki, Ei-ichiro, Asano, Yasuhisa

The structure of Escherichia blattae non-specific acid phosphatase (EB-NSAP) has been determined at 1.9 Å resolution with a bound sulfate marking the phosphate-binding site. The enzyme is a 150 kDa...

Substrate specificity of microbial transglutaminase as revealed by three-dimensional docking simulation and mutagenesis

Tagami, Uno, Shimba, Nobuhisa, Nakamura, Mina, Yokoyama, Kei-ichi, Suzuki, Ei-ichiro, Hirokawa, Takatsugu

Transglutaminases (TGases) are used in fields such as food and pharmaceuticals. Unlike other TGases, microbial transglutaminase (MTG) activity is Ca2+-independent, broadening its application. Here, a...